Haemonetics Corporation (HAE) Financials

HAE Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 2.2 billion 1.3 billion
2023-09-30 2.0 billion 1.1 billion
2023-06-30 2.0 billion 1.1 billion
2023-03-31 1.9 billion 1.1 billion

HAE Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -22.8 million 7.2 million
2023-09-30 74.5 million 6.7 million
2023-06-30 9.4 million 7.0 million
2023-03-31 67.7 million 7.1 million

HAE Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-12-31 31.2 million
2023-09-30 24.9 million
2023-06-30 41.0 million
2023-03-31 29.4 million

HAE Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 194.0 million - -
2023-09-30 351.0 million 748.7 million -
2023-06-30 285.7 million 751.4 million -
2023-03-31 284.5 million 754.1 million -

HAE Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 51.4 million
2023-09-30 51.4 million
2023-06-30 51.3 million
2023-03-31 51.2 million

HAE Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 22.3 million 13.3 million 111.7 million -
2023-09-30 24.7 million 12.7 million 104.9 million -
2023-06-30 9.7 million 12.6 million 93.5 million -
2023-03-31 11.9 million 15.6 million 90.2 million 7.2 million

HAE Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 336.3 million 158.4 million
2023-09-30 318.2 million 147.7 million
2023-06-30 311.3 million 144.1 million
2023-03-31 304.4 million 148.2 million

HAE

Price: $90.99

52 week price:
70.74
95.26

Earnings Per Share: 2.45 USD

P/E Ratio: 30.65

Exchange: NYQ

Sector: Healthcare

Industry: Medical Instruments & Supplies

Volume: 121503

Ebitda: 23.3 million

Market Capitalization: 4.3 billion

Links: